These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8465412)

  • 41. IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs.
    Oliveira TM; Mineo TW; Bason M; Day MJ; Machado RZ
    Vet Parasitol; 2009 May; 162(1-2):16-22. PubMed ID: 19345019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
    Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
    Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leishmania-HIV interaction: immunopathogenic mechanisms.
    Wolday D; Berhe N; Akuffo H; Britton S
    Parasitol Today; 1999 May; 15(5):182-7. PubMed ID: 10322351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum.
    Akhoundi B; Mohebali M; Shojaee S; Jalali M; Kazemi B; Bandehpour M; Keshavarz H; Edrissian GH; Eslami MB; Malekafzali H; Kouchaki A
    Exp Parasitol; 2013 Mar; 133(3):307-13. PubMed ID: 23276878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between leishmaniasis and AIDS: the second 10 years.
    Alvar J; Aparicio P; Aseffa A; Den Boer M; Cañavate C; Dedet JP; Gradoni L; Ter Horst R; López-Vélez R; Moreno J
    Clin Microbiol Rev; 2008 Apr; 21(2):334-59, table of contents. PubMed ID: 18400800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leishmania/HIV co-infection in Brazil: an appraisal.
    Rabello A; Orsini M; Disch J
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():17-28. PubMed ID: 14678630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.
    Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A
    Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic involvement in co-infection visceral leishmaniasis and HIV: histological and ultrastructural aspects.
    Chehter EZ; Longo MA; Laudanna AA; Duarte MI
    Rev Inst Med Trop Sao Paulo; 2001; 43(2):75-8. PubMed ID: 11340479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
    Donaghy L; Gros F; Amiot L; Mary C; Maillard A; Guiguen C; Gangneux JP
    Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation between canine cutaneous and visceral leishmaniasis by the detection of immunoglobulin G specific for Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens using flow cytometry.
    Santiago Mde A; Ribeiro FC; Mouta-Confort E; Nascimento LD; Schubach Ade O; Madeira Mde F; Bertho AL
    Vet Parasitol; 2008 Jul; 154(3-4):341-6. PubMed ID: 18462885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for subclinical Leishmania infection in HIV-infected patients living in eastern Spain.
    Ena J; Pasquau F; del Mar López-Perezagua M; Martinez-Peinado C; Arjona F
    Pathog Glob Health; 2014 Dec; 108(8):356-61. PubMed ID: 25468205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis.
    Gomes IT; Carvalho SF; Rocha RD; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
    J Immunol Methods; 2010 Aug; 360(1-2):76-83. PubMed ID: 20598707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Visceral leishmaniasis in HIV infection. A totally opportunistic infection].
    Cabié A; Matheron S; Leprètre A; Bouchaud O; Deluol AM; Coulaud JP
    Presse Med; 1992 Oct; 21(35):1658-62. PubMed ID: 1480565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
    Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
    J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study.
    Van Weyenbergh J; Santana G; D'Oliveira A; Santos AF; Costa CH; Carvalho EM; Barral A; Barral-Netto M
    BMC Infect Dis; 2004 Nov; 4():50. PubMed ID: 15546498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.
    Montalban C; Calleja JL; Erice A; Laguna F; Clotet B; Podzamczer D; Cobo J; Mallolas J; Yebra M; Gallego A
    J Infect; 1990 Nov; 21(3):261-70. PubMed ID: 2273273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
    Leite de Sousa-Gomes M; Romero GAS; Werneck GL
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005772. PubMed ID: 28945816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.
    Medrano FJ; Rey C; Leal M; Cañavate C; Rubio A; Sánchez-Quijano A; Alvar J; Lissen E
    Clin Exp Immunol; 1998 Dec; 114(3):403-7. PubMed ID: 9844050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
    Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
    Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.